Versant Venture Management as of Sept. 30, 2022
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 55.5 | $33M | 499k | 65.35 | |
| Gritstone Oncology Common Stock (GRTS) | 15.6 | $9.2M | 3.6M | 2.57 | |
| Passage Bio Common Stock (PASG) | 10.6 | $6.2M | 5.0M | 1.25 | |
| Adverum Biotechnologies Common Stock | 8.2 | $4.8M | 5.1M | 0.95 | |
| Aligos Therapeutics Common Stock (ALGS) | 4.4 | $2.6M | 2.3M | 1.10 | |
| CymaBay Therapeutics Common Stock | 3.2 | $1.9M | 544k | 3.50 | |
| Minerva Surgical Common Stock | 2.3 | $1.3M | 1.7M | 0.80 | |
| Clovis Oncology Common Stock | 0.2 | $121k | 102k | 1.19 |
